Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LET-60 RAS Inhibitors

LET-60 RAS inhibitors belong to a class of chemical compounds specifically designed to target and modulate the activity of the LET-60 RAS protein, also known as Ras GTPase LET-60. RAS proteins are pivotal components of cell signaling pathways, particularly in regulating cell growth, proliferation, and differentiation. The LET-60 RAS protein is a key member of this family and is highly conserved across various species, from nematodes to humans. Inhibitors designed to target LET-60 RAS are primarily employed in molecular and cellular biology research to investigate the functional properties and regulatory mechanisms associated with this protein.

The development of LET-60 RAS inhibitors typically involves a combination of biochemical, biophysical, and structural approaches aimed at identifying or designing molecules that can selectively interact with LET-60 RAS and modulate its activity within cellular signaling pathways. By inhibiting LET-60 RAS, these compounds can disrupt its role as a molecular switch that toggles between an active GTP-bound state and an inactive GDP-bound state, thereby impacting downstream signaling events. Researchers use LET-60 RAS inhibitors to explore the intricate roles played by this protein in cellular functions, attempting to unravel its contributions to cell cycle regulation, proliferation, and differentiation processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$32.00
$86.00
$150.00
3
(1)

Sulindac metabolites can inhibit Ras signaling indirectly, which might lead to reduced expression of LET-60 RAS through feedback loops.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$29.00
$90.00
$339.00
12
(1)

Lovastatin inhibits HMG-CoA reductase, potentially affecting the prenylation and function of RAS, which may influence LET-60 RAS expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could disrupt downstream signaling pathways and indirectly decrease LET-60 RAS expression.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Manumycin A is a farnesyltransferase inhibitor, which can block RAS prenylation and possibly reduce LET-60 RAS expression levels.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

Tipifarnib, an inhibitor of farnesyltransferase, might interfere with RAS processing and indirectly decrease LET-60 RAS expression.

Lonafarnib

193275-84-2sc-482730
sc-482730A
5 mg
10 mg
$173.00
$234.00
(0)

Lonafarnib is another farnesyltransferase inhibitor, potentially affecting RAS function and indirectly its expression.